Possible role of exogenous melatonin in preventing more serious COVID-19 infection in patients with type 2 diabetes mellitus
Rev. Assoc. Med. Bras. (1992)
;
67(supl.1): 18-21, 2021.
Article
in English
| LILACS
| ID: biblio-1287838
ABSTRACT
SUMMARY COVID-19 infection is more severe in patients with type 2 diabetes mellitus (DM2). The severity of this viral infection is associated with an intense inflammatory activity. DM2 is a disease that also determines a greater degree of systemic inflammation. This is due to hyperglycemia, the higher prevalence of sleep disorders and also the low levels of melatonin, a substance with anti-inflammatory actions, in these patients. In this article, we suggest that exogenous melatonin may have an important anti-inflammatory role in preventing severe forms of COVID -19 in patients with DM2.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Diabetes Mellitus, Type 2
/
COVID-19
/
Hyperglycemia
Type of study:
Risk factors
Language:
English
Journal:
Rev. Assoc. Med. Bras. (1992)
Year:
2021
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Universidade Federal de Minas Gerais/BR
Similar
MEDLINE
...
LILACS
LIS